Skip to main content

Global Contraceptives Market Breached $20 Billion in 2018

The global contraceptives market size was around $21 billion in 2018 and anticipated to flourish at a CAGR of 7% over the forecast period 2019-2025.

Hyderabad, India - August 1, 2019 /MarketersMedia/

Global Contraceptives Market: Demand Analysis and Growth Forecast

The advent of oral contraceptive drugs, which are highly effective along with reduced side effects, has opened new frontiers for the global contraceptives market. According to a recent business publication by IndustryARC, the global contraceptives market size was around $21 billion in 2018 and anticipated to flourish at a CAGR of 7% over the forecast period 2019-2025. Rising awareness towards sexually transmitted infections and government ardent efforts to promote the use of contraceptives, which helps to reduce the rate of unintended pregnancies are increasing demand for contraceptives worldwide. The rapid growth in consumer base of contraceptives is mainly due to the increasing unstable relationships cases. It is also used to postpone the motherhood, and to prioritize the careers of individuals.

The report titled “Contraceptives Market: By Product (Drug, Devices); By End-User (Hospital, Clinic, Home Care, Ambulatory Surgical Centre) & By region – Forecast (2019 - 2025),”includes a meticulous analysis of growth factors, drivers, leading segments and key trends of the global contraceptives market. This report covers Contraceptives Market Size by product and end-user, Contraceptives Market share by top 5 companies and also the market share by start-ups during the forecast period.

View Full Table of Contents of Contraceptives Market:
https://www.industryarc.com/Report/16390/contraceptives-market.html

Report Price (Single User): US $3850

Contraceptives Market: Leading Segments

As per the findings of Centres for Disease Control and Prevention, around 38,739 people in the U.S. were effected by HIV in 2017. The increasing prevalence of various sexually transmitted diseases such as HIV, genital herpes and trichomoniasis are proliferating the growth of contraceptives market in North America. Hence, this region accounted for a massive share in the global contraceptives market, which is around 28% to 30% in 2018.

Intrauterine devices (IUT) are the prominent product type, which is projected to grow at CAGR of around 30% to 35% during the aforementioned forecast period. Widespread adoption of these devices is mainly because it is more effective as compared to other devices. It prevents pregnancy and lasts for around five to ten years. The usage of IUT does not affect the weight of the person, which is the notable advantage of these devices.

Contraceptives Market Trends

The advent of chewable contraceptive pills is boosting the global contraceptives market. These birth control pills helps in controlling menstruation and reduces the risks of ovarian cysts. The additional benefit provided by chewable contraceptive pill is it helps in treating acne and protect from sexually transmitted diseases.

Extended Regimen Combined Oral Contraception is the latest advancement which is more effective and safe option for birth control. This mainly helps in controlling hormonal changes and cyclical symptoms like headaches, menstruation and mood changes.

In November, 2017 Teva Pharmaceutical Industries Limited signed a treaty with CooperSurgical, to acquire PARAGARD, an intrauterine contraceptive product. This agreement was valued about $1.1 billion. The main goal of Teva regarding this acquisition is to expand the IUT devices portfolio by improving its production base to meet the consumer needs for postponing mother hood.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=16390

Global Contraceptives Market: Competitive Landscape

Some of the key companies identified in the report that are currently holding majority shares in the global contraceptives market are Cooper Surgical, Inc., Pfizer, Inc., Actavis, Inc.Teva Pharmaceutical Industries Limited, Bayer AG), The Female Health Company, Merck & Co., Inc., Mayer Laboratories, Inc., Church & Dwight, Co., Inc., and Medisafe Distribution Inc.

Related Reports:

A. Hormonal Contraception Market Analysis:
https://www.industryarc.com/Report/15879/hormonal-contraception-market.html

B. Contraceptive Drugs and Devices Market:
https://www.industryarc.com/Research/Contraceptive-Drugs-And-Devices-Market-Research-504172

About IndustryARC:

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: +1-614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/global-contraceptives-market-breached-20-billion-in-2018/88902842

Source: MarketersMedia

Release ID: 88902842

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.